The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often at Series D+ and in Healthtech.
Venture capitalhealthquestcapital.comRounds from 2024-08-15 to 2026-09-02
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series E Verified against 4 of 8 sources | $125M | 2026-09-02 | [ PART ] |
OrganOx OrganOx advances liver transplantation with normothermic perfusion to extend preservation and improve patient outcomes. | Venture – Series Unknown |
| $142M |
| 2025-02-27 |
| [ LEAD ] |
HistoSonics HistoSonics® is developing a non-invasive, robotically assisted platform capable of destroying tissue at a sub-cellular level. | Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $102M | 2024-08-15 | [ PART ] |